ciPARTHENON™ Accelerates Rare Disease Solutions through Partnership with Ambit
CustomerInsights.AI (CIAI)
andAmbit
, two leading companies in the rare disease space, have partnered to provide comprehensive solutions for companies in this field.ciPARTHENON™, CIAI’s
no-code analytics platform, offers tailored data management and analytics solutions for Life Sciences companies.Ambit
, on the other hand, provides consulting services specifically designed for rare and specialty disease companies.The partnership between
ciPARTHENON™
andAmbit
aims to address the unique challenges faced by companies in the rare disease space. By leveragingciPARTHENON™
’s scalable architecture and AI capabilities, andAmbit
’s consulting expertise, the partnership will help companies accelerate the development and deployment of data and analytics solutions.This collaboration will provide unparalleled value to Life Sciences companies, helping them navigate the complexities of diagnosis, treatment, and disease management for rare diseases. The partnership underscores the shared commitment of both companies to innovation, excellence, and customer success.
About CustomerInsights.AI (CIAI)
CIAI is a provider of technology-enabled solutions for Life Sciences companies. Its commercial Analytics cloud, ciPARTHENON™, is a ready-to-deploy, no-code, unified data management and analytics platform with 40+ vertical Apps across Sales Operations & Analytics, Customer Engagement, Market Access, and Information Management specifically designed for Life Sciences companies.
About Ambit
Ambit is a technology-enabled solutions firm helping biopharma companies face and conquer their biggest challenges. Its services are built on a foundation of technology and data and refined through decades of experience in consulting, biopharma commercial, medical, digital, and data science roles, and are designed to address the challenges that rare and specialty disease companies face.
